Professor Steve Bain
Professor in Medicine(Diabetes)
Swansea University Medical School
Telephone: (01792) 602205

Professor Steve Bain is Assistant Medical Director for Research & Development for ABM University Health Board and Clinical Lead for the Diabetes Research Network, Wales.
After undergraduate training at St John's College, Cambridge, he was clinically trained at King's College Hospital, London. Qualifying in 1983, he held junior appointments in London, East Midlands, and West Midlands. His research centred on the genetics of type 1 diabetes, and he was granted a Medical Research Council Lecturership. In 1993, he became a Senior Lecturer/Honorary Consultant Physician at Birmingham Heartlands Hospital, with promotion to Reader in Diabetic Medicine in 1998. Professor Bain became a Fellow of the Royal College of Physicians, UK, in 1996 and was appointed to a newly created Chair in Medicine (Diabetes) at Swansea University in 2005. His clinical interests include the genetics of diabetic nephropathy, new therapies for diabetes and the provision of diabetes services within the community. He has been Principal Investigator for several multi-centre trials investigating novel therapies for diabetes.
As a result of his genetics background, Professor Bain became a member of the inaugural West Midlands Multicentre Research Ethics Committee (MREC) and joined the UK Human Genetics Commission. From 2003-2008 he was HGC’s nomination on the National DNA Database Strategy Board and led the HGC report on DNA testing in 2009. In 2007 he was invited to sit on the newly formed National DNA Database Ethics Group, established by the Secretary of State for the Home Department. Professor Bain is Diabetes Lead Clinician for ABM University Health Board, a member of the Wales Diabetes & Endocrine Society (WEDS) executive committee and chairs the Specialist Training Committee for Diabetes & Endocrinology for Wales. He is also on the Board which oversees the ILS Joint Clinical Research Facility, the premier clinical research institute in Wales and is Clinical Director of the Academic Health Science Collaboration for Wales.

Areas of Expertise

  • R&D


  1. & Association of British Clinical Diabetologists (ABCD) and Renal Association clinical guidelines: Hypertension management and renin-angiotensin-aldosterone system blockade in patients with diabetes, nephropathy and/or chronic kidney disease. British Journal of Diabetes 17(4), 160-164.
  2. & Mechanism of cardiovascular disease benefit of glucagon-like peptide 1 agonists. Cardiovascular Endocrinology, 1
  3. & Poor glycaemic control is associated with reduced exercise performance and oxygen economy during cardio-pulmonary exercise testing in people with type 1 diabetes. Diabetology & Metabolic Syndrome 9(1)
  4. & Semaglutide.. Drugs of the Future
  5. & Semaglutide, reduction in glycated haemoglobin and the risk of diabetic retinopathy. Diabetes, Obesity and Metabolism

See more...


  • Interstitial glucose monitoring around exercise in individuals with type 1 diabetes (current)

    Student name:
    Other supervisor: Dr Richard Bracken
  • Studying the underlying mechanisms of the GLP-1 receptor agonists treatment for diabesity«br /»«br /» (current)

    Student name:
    Other supervisor: Prof Venkat Kanamarlapudi
  • The Influence of acute Resistance Exercise and/or Dietary Supplementation in Individuals with Type 1 Diabetes (current)

    Student name:
    Other supervisor: Dr Richard Bracken
  • 'Temporal Effects of Bariatric Surgery on Cardiovascular Risk, Glucose Metabolism and Inflammation at 5 years Follow-Up' (current)

    Student name:
    Other supervisor: Prof Jeffrey Stephens
  • no change needed (current)

    Student name:
    Other supervisor: Prof Ronan Lyons